Vanberra Signal
Flowcast logo

Flowcast

Curated by Signal

AI-driven risk and compliance solutions for financial institutions' credit decisions.

Overview

Flowcast focuses on delivering risk and compliance solutions for financial institutions through its RegTech offerings. The platform incorporates artificial intelligence and machine learning to automate compliance processes, monitor transactions, and ensure compliance with regulatory standards. It utilizes blockchain technology to secure data integrity and establish an immutable audit trail for regulatory purposes. Flowcast's product suite includes machine learning models, API-based solutions, and analytics tools aimed at improving credit decision-making and risk assessment. The company targets financial institutions and seeks to address the challenges of accurately measuring financial risk, thereby facilitating better credit decisions and proactive risk management within a complex regulatory framework.

Key facts

Founded
2015

Business model

Contact

More on Vanberra Signal

Members only
  • Risk and compliance solutions leveraging AI for financial institutions' decisions.

    Compliance & Regulatory TechnologyNew York City, United States
  • Risk and compliance solutions automating third-party risk management processes.

    Compliance & Regulatory TechnologyIsrael
  • Operational risk solutions enhancing compliance for financial institutions globally.

    Compliance & Regulatory TechnologyLondon, United Kingdom
+ 197 more similar companies on Signal

About Flowcast

What does Flowcast do?

Flowcast focuses on delivering risk and compliance solutions for financial institutions through its RegTech offerings.

Where is Flowcast headquartered?

Flowcast is headquartered in San Francisco, United States.

When was Flowcast founded?

Flowcast was founded in 2015.

Which sector is Flowcast in?

Flowcast operates in Compliance & Regulatory Technology, part of Financial Technology.

Who are Flowcast's competitors?

Companies similar to Flowcast include Stratyfy, Mirato, and Acin.